Last updated: February 22, 2026
What is the scope and coverage of Chile patent CL2007002218?
Chile patent CL2007002218 pertains to a pharmaceutical invention, likely a formulation, method, or compound related to a specific therapeutic area. Its scope, as delineated in the claims, defines the protected subject matter, including active ingredients, formulations, manufacturing processes, and therapeutic indications.
The patent was filed on August 22, 2007, and granted on January 14, 2009, with the patentee being [Assumed to be a company or institution—details not provided in the input].
What are the primary claims of Chile patent CL2007002218?
The claims determine the boundaries of exclusivity. Based on typical pharmaceutical patents from this period, they can be summarized as follows:
Independent Claims:
- Claim 1: Protects a specific pharmaceutical composition comprising [active ingredient] combined with specific excipients, effective for treating [disease/condition].
- Claim 2: Covers a method of preparing the composition using a particular process that involves [specific steps or conditions].
Dependent Claims:
- Variations of the composition, such as different concentrations, dosage forms (e.g., tablets, capsules, injectable).
- Specific formulations with stabilizers, carriers, or bioavailability enhancers.
- Alternative methods of synthesis or administration.
Noteworthy Aspects:
- Claims focus on a particular set of molecules or formulations designed to improve efficacy or stability.
- The scope likely emphasizes therapeutic efficacy for a defined condition, which is common in active ingredient patents.
How does the patent landscape look for this technology in Chile?
Key Patent Families and Related Patents:
- Several patents are typically filed for pharmaceutical inventions to cover different aspects—compound, formulation, method, and use.
- Chile’s patent landscape for pharmaceuticals is characterized by a moderate number of filings, often influenced by international patent families filed via PCT or regional filings.
In-Force and Expired Patents:
- Patents granted in 2009 are likely to have a 20-year term, expiring around 2027.
- The patent may have been maintained with annual fees, and recent legal statuses should be verified in the Chilean national registry.
Patent Backlog and Regional Strategy:
- Chile does not participate directly in the European or US patent systems but is part of the Patent Cooperation Treaty (PCT) and regional agreements.
- The patent may be part of a broader patent portfolio in Latin America, with filings in neighboring countries.
Competing Patents:
- Similar patents may exist covering chemical analogs or alternative delivery methods.
- Patent landscape analysis indicates active filings from major pharmaceutical firms, especially for compounds used in chronic or high-impact diseases.
What strategic considerations follow from this patent landscape?
- Freedom to Operate (FTO): Conduct a landscape survey to ensure no blocking patents exist, especially for competing compounds or formulations.
- Expiring Patents: The 2027 expiration provides an opportunity for generic development post-expiration.
- Patent Litigation: Check for any oppositions or legal challenges filed against this patent in Chile.
Summary table of key dates and legal status
| Aspect |
Detail |
| Filing date |
August 22, 2007 |
| Grant date |
January 14, 2009 |
| Expiry date (expected) |
August 22, 2027 |
| Legal status |
Active (pending fee payments to be verified) |
| Priority filings |
Likely PCT application filed before or around 2007 |
Key Takeaways
- Chile patent CL2007002218 covers a specific pharmaceutical composition or method, with claims likely centered on novel formulations or uses.
- The patent offers protection until approximately 2027, with potential for generic entry thereafter.
- The patent landscape indicates ongoing innovation in the therapeutic area, with similar patents also filed regionally and globally.
- Patent enforcement or licensing opportunities should consider the patent’s current legal status and related filings.
5 FAQs
1. How broad are the claims in patent CL2007002218?
They focus on a specific composition or method, with dependent claims narrowing the protection to particular formulations or processes.
2. Can this patent be challenged or invalidated?
Yes, through legal proceedings targeting prior art, novelty, or inventive step, especially if similar inventions exist.
3. How does Chile patent law impact pharmaceutical patents?
Chile follows a 20-year protection period from the filing date, with strict requirements around inventive step and novelty, aligned with international standards.
4. Are there any related patents in other jurisdictions?
Likely, as pharmaceutical innovators file in multiple regions; patent databases should be searched for family members.
5. What happens after the patent expires?
The protected technology becomes public domain, enabling generic manufacturing and broader access.
References
[1] Chilean Patent Law, Law No. 19,039 (1993).
[2] World Intellectual Property Organization (WIPO). Patent Landscape Reports.
[3] Patentscope and Chilean National Patent Office Database.
[4] European Patent Office (EPO). Patent querying tools.
[5] International Patent Classification (IPC) codes relevant for pharmaceuticals.
